Publications by authors named "Rodolfo Bordoni"

Claim this Profile
B
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy.
Jonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly, Timothy Larson, Jerome Goldschmidt

Blood· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies.
Amer M Zeidan, Rachel J Cook, Rodolfo Bordoni, James R Berenson, William J Edenfield

Clin Lymphoma Myeloma Leuk· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.
Makoto Nishio, Fabrice Barlesi, Howard West, Simon Ball, Rodolfo Bordoni

J Thorac Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
Rodolfo Bordoni, Fortunato Ciardiello, Joachim von Pawel, Diego Cortinovis, Thomas Karagiannis

Clin Lung Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.
Alexa B Schrock, Dean Pavlick, Samuel J Klempner, Jon H Chung, Brady Forcier, Rodolfo Bordoni

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.
Jonathan W Friedberg, Andres Forero-Torres, Rodolfo E Bordoni, Vivian J M Cline, Dipti Patel Donnelly

Blood· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
Ankit Madan, Benjamin S Jones, Rodolfo Bordoni, Mansoor N Saleh, Mary S Jerome

Cancer Chemother Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Alexa B Schrock, Garrett M Frampton, Dana Herndon, Joel R Greenbowe, Kai Wang, Rodolfo Bordoni

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of BRAF Kinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy.
Samuel J Klempner, Rodolfo Bordoni, Kyle Gowen, Henry Kaplan, Philip J Stephens

JAMA Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.
Andres Forero-Torres, Beata Holkova, Jerome Goldschmidt, Robert Chen, Gregg Olsen, Rodolfo E Bordoni

Blood· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Daniel J Allendorf, Rodolfo E Bordoni, Stefan C Grant, Mansoor N Saleh, Vishnu B Reddy

Cancer Chemother Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cushing's syndrome due to ectopic adrenocorticotrophic hormone production by olfactory neuroblastoma.
Nitin Mayur, Rodolfo E Bordoni, Drew Locandro, Mark McLaughlin

Endocr Pract· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic outcomes of myelodysplastic syndromes treatment with hypomethylating agents in community practice.
Rodolfo E Bordoni, Bruce A Feinberg, James W Gilmore, Sally Haislip, James H Jackson

Clin Lymphoma Myeloma Leuk· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
Mauricio Zapata, Steven D Budnick, Rodolfo Bordoni, Shiyong Li

Int J Clin Exp Pathol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
Rodolfo Bordoni

Oncologist· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis